| UniProt ID | MAP9_HUMAN | |
|---|---|---|
| UniProt AC | Q49MG5 | |
| Protein Name | Microtubule-associated protein 9 | |
| Gene Name | MAP9 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 647 | |
| Subcellular Localization | Cytoplasm . Cytoplasm, cytoskeleton . Cytoplasm, cytoskeleton, spindle . Localizes to microtubules in interphase, associates with the mitotic spindle during mitosis, localizes to the central body during cytokinesis. | |
| Protein Description | Involved in organization of the bipolar mitotic spindle. Required for bipolar spindle assembly, mitosis progression and cytokinesis. May act by stabilizing interphase microtubules.. | |
| Protein Sequence | MSDEVFSTTLAYTKSPKVTKRTTFQDELIRAITARSARQRSSEYSDDFDSDEIVSLGDFSDTSADENSVNKKMNDFHISDDEEKNPSKLLFLKTNKSNGNITKDEPVCAIKNEEEMAPDGCEDIVVKSFSESQNKDEEFEKDKIKMKPKPRILSIKSTSSAENNSLDTDDHFKPSPRPRSMLKKKSHMEEKDGLEDKETALSEELELHSAPSSLPTPNGIQLEAEKKAFSENLDPEDSCLTSLASSSLKQILGDSFSPGSEGNASGKDPNEEITENHNSLKSDENKENSFSADHVTTAVEKSKESQVTADDLEEEKAKAELIMDDDRTVDPLLSKSQSILISTSATASSKKTIEDRNIKNKKSTNNRASSASARLMTSEFLKKSSSKRRTPSTTTSSHYLGTLKVLDQKPSQKQSIEPDRADNIRAAVYQEWLEKKNVYLHEMHRIKRIESENLRIQNEQKKAAKREEALASFEAWKAMKEKEAKKIAAKKRLEEKNKKKTEEENAARKGEALQAFEKWKEKKMEYLKEKNRKEREYERAKKQKEEETVAEKKKDNLTAVEKWNEKKEAFFKQKEKEKINEKRKEELKRAEKKDKDKQAINEYEKWLENKEKQERIERKQKKRHSFLESEALPPWSPPSRTVFAKVF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MSDEVFSTT ------CCCCCHHCE | 42.34 | 19413330 | |
| 2 | Phosphorylation | ------MSDEVFSTT ------CCCCCHHCE | 42.34 | 23663014 | |
| 7 | Phosphorylation | -MSDEVFSTTLAYTK -CCCCCHHCEECCCC | 26.17 | 23663014 | |
| 8 | Phosphorylation | MSDEVFSTTLAYTKS CCCCCHHCEECCCCC | 17.86 | 19690332 | |
| 9 | Phosphorylation | SDEVFSTTLAYTKSP CCCCHHCEECCCCCC | 14.27 | 23663014 | |
| 12 | Phosphorylation | VFSTTLAYTKSPKVT CHHCEECCCCCCCCC | 20.15 | 23663014 | |
| 13 | Phosphorylation | FSTTLAYTKSPKVTK HHCEECCCCCCCCCC | 21.31 | 23663014 | |
| 15 | Phosphorylation | TTLAYTKSPKVTKRT CEECCCCCCCCCCCC | 23.35 | 23663014 | |
| 19 | Phosphorylation | YTKSPKVTKRTTFQD CCCCCCCCCCCCCHH | 22.42 | 26074081 | |
| 22 | Phosphorylation | SPKVTKRTTFQDELI CCCCCCCCCCHHHHH | 33.25 | 26074081 | |
| 41 | Phosphorylation | ARSARQRSSEYSDDF HHHHHHHCCCCCCCC | 21.13 | - | |
| 79 (in isoform 2) | Phosphorylation | - | 30.36 | 21406692 | |
| 79 | Phosphorylation | KMNDFHISDDEEKNP HHCCCCCCCCCCCCH | 30.36 | 30266825 | |
| 87 | Phosphorylation | DDEEKNPSKLLFLKT CCCCCCHHHEEEEEE | 45.38 | 23927012 | |
| 128 | Phosphorylation | CEDIVVKSFSESQNK CCEEEEECCCHHCCC | 23.54 | - | |
| 130 | Phosphorylation | DIVVKSFSESQNKDE EEEEECCCHHCCCCH | 43.35 | - | |
| 132 | Phosphorylation | VVKSFSESQNKDEEF EEECCCHHCCCCHHH | 37.54 | 17525332 | |
| 154 | Phosphorylation | KPKPRILSIKSTSSA CCCCCEEEEECCCCC | 26.12 | 24719451 | |
| 157 | Phosphorylation | PRILSIKSTSSAENN CCEEEEECCCCCCCC | 31.67 | 29978859 | |
| 158 | Phosphorylation | RILSIKSTSSAENNS CEEEEECCCCCCCCC | 23.00 | 29978859 | |
| 159 | Phosphorylation | ILSIKSTSSAENNSL EEEEECCCCCCCCCC | 34.34 | 29978859 | |
| 160 | Phosphorylation | LSIKSTSSAENNSLD EEEECCCCCCCCCCC | 39.42 | 29978859 | |
| 165 | Phosphorylation | TSSAENNSLDTDDHF CCCCCCCCCCCCCCC | 38.92 | 29978859 | |
| 175 | Phosphorylation | TDDHFKPSPRPRSML CCCCCCCCCCCHHHH | 33.85 | 27251275 | |
| 180 | Phosphorylation | KPSPRPRSMLKKKSH CCCCCCHHHHHHHHC | 31.02 | 27251275 | |
| 209 | Phosphorylation | SEELELHSAPSSLPT HHHHHHHCCCCCCCC | 55.27 | 25921289 | |
| 212 | Phosphorylation | LELHSAPSSLPTPNG HHHHCCCCCCCCCCC | 44.20 | 25921289 | |
| 238 | Phosphorylation | ENLDPEDSCLTSLAS CCCCHHHHHHHHHHH | 14.90 | 28348404 | |
| 241 | Phosphorylation | DPEDSCLTSLASSSL CHHHHHHHHHHHHHH | 26.48 | 28348404 | |
| 242 | Phosphorylation | PEDSCLTSLASSSLK HHHHHHHHHHHHHHH | 14.69 | 28348404 | |
| 245 | Phosphorylation | SCLTSLASSSLKQIL HHHHHHHHHHHHHHH | 26.25 | 28348404 | |
| 246 | Phosphorylation | CLTSLASSSLKQILG HHHHHHHHHHHHHHC | 33.80 | 28348404 | |
| 247 | Phosphorylation | LTSLASSSLKQILGD HHHHHHHHHHHHHCC | 36.77 | 28348404 | |
| 255 | Phosphorylation | LKQILGDSFSPGSEG HHHHHCCCCCCCCCC | 26.31 | 29978859 | |
| 257 | Phosphorylation | QILGDSFSPGSEGNA HHHCCCCCCCCCCCC | 32.10 | 29978859 | |
| 260 | Phosphorylation | GDSFSPGSEGNASGK CCCCCCCCCCCCCCC | 45.79 | 29978859 | |
| 265 | Phosphorylation | PGSEGNASGKDPNEE CCCCCCCCCCCCCHH | 50.83 | 29978859 | |
| 279 | Phosphorylation | EITENHNSLKSDENK HHHCCHHCCCCCCCC | 29.62 | 25627689 | |
| 282 | Phosphorylation | ENHNSLKSDENKENS CCHHCCCCCCCCCCC | 56.29 | 22617229 | |
| 289 | Phosphorylation | SDENKENSFSADHVT CCCCCCCCCCHHHHH | 22.97 | 25849741 | |
| 291 | Phosphorylation | ENKENSFSADHVTTA CCCCCCCCHHHHHHH | 32.38 | 30377224 | |
| 296 | Phosphorylation | SFSADHVTTAVEKSK CCCHHHHHHHHHHHH | 12.96 | 29449344 | |
| 305 | Phosphorylation | AVEKSKESQVTADDL HHHHHHHHCCCHHHH | 33.42 | 25159151 | |
| 336 | Phosphorylation | VDPLLSKSQSILIST CCHHHCCCCEEEEEC | 26.28 | 27251275 | |
| 338 | Phosphorylation | PLLSKSQSILISTSA HHHCCCCEEEEECCC | 26.84 | 28348404 | |
| 343 | Phosphorylation | SQSILISTSATASSK CCEEEEECCCCCCCC | 18.52 | - | |
| 349 | Phosphorylation | STSATASSKKTIEDR ECCCCCCCCCCHHHH | 35.39 | - | |
| 363 | Phosphorylation | RNIKNKKSTNNRASS HCCCCCCCCCCCHHH | 37.67 | 26074081 | |
| 364 | Phosphorylation | NIKNKKSTNNRASSA CCCCCCCCCCCHHHH | 45.45 | 26074081 | |
| 369 | Phosphorylation | KSTNNRASSASARLM CCCCCCHHHHHHHHH | 24.17 | 26074081 | |
| 370 | Phosphorylation | STNNRASSASARLMT CCCCCHHHHHHHHHH | 25.84 | 26074081 | |
| 372 | Phosphorylation | NNRASSASARLMTSE CCCHHHHHHHHHHHH | 18.83 | 26074081 | |
| 377 | Phosphorylation | SASARLMTSEFLKKS HHHHHHHHHHHHHHC | 29.69 | 26074081 | |
| 378 | Phosphorylation | ASARLMTSEFLKKSS HHHHHHHHHHHHHCC | 16.64 | 26074081 | |
| 385 | Phosphorylation | SEFLKKSSSKRRTPS HHHHHHCCCCCCCCC | 49.08 | - | |
| 390 | Phosphorylation | KSSSKRRTPSTTTSS HCCCCCCCCCCCCCH | 26.14 | 29978859 | |
| 392 | Phosphorylation | SSKRRTPSTTTSSHY CCCCCCCCCCCCHHH | 37.46 | 29978859 | |
| 393 | Phosphorylation | SKRRTPSTTTSSHYL CCCCCCCCCCCHHHH | 34.98 | 29978859 | |
| 394 | Phosphorylation | KRRTPSTTTSSHYLG CCCCCCCCCCHHHHH | 29.08 | 29978859 | |
| 395 | Phosphorylation | RRTPSTTTSSHYLGT CCCCCCCCCHHHHHE | 28.46 | 29449344 | |
| 396 | Phosphorylation | RTPSTTTSSHYLGTL CCCCCCCCHHHHHEE | 17.02 | 29978859 | |
| 397 | Phosphorylation | TPSTTTSSHYLGTLK CCCCCCCHHHHHEEE | 17.66 | 29978859 | |
| 399 | Phosphorylation | STTTSSHYLGTLKVL CCCCCHHHHHEEEEC | 14.58 | 29978859 | |
| 402 | Phosphorylation | TSSHYLGTLKVLDQK CCHHHHHEEEECCCC | 22.32 | 29978859 | |
| 429 | Phosphorylation | DNIRAAVYQEWLEKK HHHHHHHHHHHHHHC | 8.93 | 27642862 | |
| 451 | Phosphorylation | HRIKRIESENLRIQN HHHHHHHHHCHHCCH | 29.43 | 28857561 | |
| 496 | Acetylation | AKKRLEEKNKKKTEE HHHHHHHHHHHHHHH | 65.77 | 20167786 | |
| 603 | Phosphorylation | DKQAINEYEKWLENK HHHHHHHHHHHHHCH | 20.51 | - | |
| 625 | Phosphorylation | RKQKKRHSFLESEAL HHHHHHHCHHHCCCC | 35.24 | 29514088 | |
| 629 | Phosphorylation | KRHSFLESEALPPWS HHHCHHHCCCCCCCC | 30.25 | 29514088 | |
| 636 | Phosphorylation | SEALPPWSPPSRTVF CCCCCCCCCCCCCEE | 32.48 | 27251275 | |
| 639 | Phosphorylation | LPPWSPPSRTVFAKV CCCCCCCCCCEEEEC | 43.92 | 29449344 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MAP9_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MAP9_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| P53_HUMAN | TP53 | physical | 22672907 | |
| EP300_HUMAN | EP300 | physical | 22672907 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-15 AND SER-257, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-132, AND MASSSPECTROMETRY. | |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-12, AND MASSSPECTROMETRY. | |